Abnova produce y desarrolla mas de 19.000 proteínas recombinantes, mas de 12.000 anticuerpos MaxPab, mas de 16.000 anticuerpos monoclonales y mas de 20.000 anticuerpos policlonales dirigidos al genoma humano.
K-562 (human chronic myelogenous leukemia) whole cell lysate (denatured)
MOLT-4 (human acute lymphoblastic leukemia, T cell) whole cell lysate (denatured)
PC-12 (rat adrenal gland pheochromocytoma) whole cell lysate (denatured)
Hela (human cervical epithelioid carcinoma) whole cell lysate (denatured)
Jurkat, clone E6-1 (human acute T cell leukemia) whole cell lysate (denatured)